Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Somaxon Reports Positive FDA Feedback On Silenor OTC Pathway; Stock Surges 37%
Somaxon Reports Positive FDA Feedback On Silenor OTC Pathway; Stock Surges 37%
Somaxon Reports Positive FDA Feedback On Silenor OTC Pathway; Stock Surges 37%
Submitted by
admin
on October 4, 2011 - 12:20pm
Source:
RTT News
News Tags:
Somaxon
OTC
Silenor
FDA
insomnia
Headline:
Somaxon Reports Positive FDA Feedback On Silenor OTC Pathway; Stock Surges 37%
Do Not Allow Advertisers to Use My Personal information
